Timing of Necrosectomy After Endoscopic Drainage of Walled-off Pancreatic Necrosis (WON)

Last updated: February 22, 2022
Sponsor: Chinese University of Hong Kong
Overall Status: Active - Recruiting

Phase

N/A

Condition

Pancreatic Disorders

Pancreatitis

Treatment

N/A

Clinical Study ID

NCT05252897
2021.465-T
  • Ages > 18
  • All Genders

Study Summary

Walled-off pancreatic necrosis (WON) is associated with a mortality of 20-30%. The current evidence supports a minimally invasive drainage approach to infected WON. The current suggested approach in international guidelines is the endoscopic step-up approach. However, recent evidence from large national cohorts support the use of direct endoscopic necrosectomy (DEN) at the time of stent placement, resulting in earlier resolution of WON and less number of necrosectomies. This study aims to investigate the clinical outcomes of the DEN versus the step-up approach for necrosectomy after endoscopic drainage of WON.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Adult (≥18 years of age) patients
  2. Diagnosis of walled-off pancreatic necrosis (WON) based on imaging criteria based onthe revised Atlanta classification5
  3. Documented history of acute pancreatitis
  4. Suspected or confirmed infected WON and/or symptomatic WON causing (i) persistentpancreatic-type pain, and/or ii) gastric outlet or biliary obstruction, and/or (iii)ongoing systemic illness, anorexia, and weight loss, and/or (iv) rapidly enlargingWONs, and/or (v) infected WON*
  5. WON identified at contrast-enhanced computed tomography (CECT) and deemed amenable forEUS-guided drainage
  6. WON with a solid component >30% and/ or percentage of necrosis >= 30%

Exclusion

Exclusion Criteria:

  1. Previous invasive interventions for necrotising pancreatitis
  2. An acute flare up of chronic pancreatitis
  3. Recurrent acute pancreatitis
  4. Indicated for emergency laparotomy (i.e. abdominal compartment syndrome, perforationof a visceral organ, bleeding and bowel ischaemia)
  5. Contraindications to endoscopic drainage: previous total gastrectomy, gastric bypasssurgery, prior surgery for pancreas-related diseases
  6. WON not adherent to the GI wall or not accessible for endoscopic drainage
  7. Coagulopathy (INR >1.5), and/or thrombocytopenia (platelets <50,000/mm3)
  8. Pregnancy

Study Design

Total Participants: 108
Study Start date:
February 01, 2022
Estimated Completion Date:
June 30, 2026

Study Description

INTRODUCTION Acute pancreatitis is one of the most common gastrointestinal diseases requiring emergency admissions to the hospital. 10-20% of these patients develop pancreatic necrosis and subsequent walled-off pancreatic necrosis (WON) and is associated with a mortality of 20-30%. Grade 1A evidence exists to support an initial minimally invasive drainage approach to infected WON. However, the optimal approach and timing of necrosectomy remains unaddressed. The current suggested approach in international guidelines is the endoscopic step-up approach. However, recent evidence from large national cohorts support the use of direct endoscopic necrosectomy (DEN) at the time of stent placement, resulting in earlier resolution of WON and less number of necrosectomies.

OBJECTIVE This study aims to investigate the clinical outcomes of the DEN versus the step-up approach for necrosectomy after endoscopic drainage of WON.

HYPOTHESIS The hypothesis is that DEN at the time of LAMS placement improves clinical outcomes after endoscopic drainage of WON as compared to the endoscopic step-up approach.

DESIGN AND SUBJECTS This is a multicentre international randomized controlled trial. Patients with suspected or confirmed infected or symptomatic WON on computed tomography (CT) and who are deemed feasible for endoscopic drainage will be included in the study. Endoscopic drainage with lumen-apposing metal stents (LAMS) will be performed. Patients will be randomised to either the endoscopic step-up approach or direct endoscopic necrosectomy (DEN) approach.

The primary endpoint is a composite of major complications or death within 6 months after randomisation. Secondary endpoints include time to resolution of WON, pancreatic functions, biliary strictures, need for necrosectomy, total number of interventions, length of hospital and ICU stay, recurrence of WON and unplanned readmissions related to WON.

A reduction in cumulative primary endpoint with the DEN approach by 22.4% (32.2% to 9.8%) in comparison to endoscopic step-up approach was assumed. With a 2-sided significance level of 5% and power of 80%, taking into account a 5% drop-out rate, a total of 108 patients was required to demonstrate this effect. Study collaboration has been established with four other international centres. A estimation of 3 years is required to complete study recruitment.

Connect with a study center

  • Royal Adelaide Hospital

    Adelaide,
    Australia

    Active - Recruiting

  • The Chinese University of Hong Kong

    Hong Kong, 0000
    Hong Kong

    Active - Recruiting

  • Medanta Institute Of Digestive & Hepatobiliary Sciences

    Haryana,
    India

    Active - Recruiting

  • Asian Institute of Gastroenterology

    Hyderabad,
    India

    Active - Recruiting

  • Deenanath Mangeshkar Hospital & Research Centre

    Pune,
    India

    Active - Recruiting

  • Asan Medical Centre

    Asan,
    Korea, Republic of

    Active - Recruiting

  • SoonChunHyang University School of Medicine

    Asan,
    Korea, Republic of

    Active - Recruiting

  • Hospital Universitario Rio Hortega

    Valladolid,
    Spain

    Active - Recruiting

  • King Chulalongkorn Memorial Hospital

    Bangkok,
    Thailand

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.